Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
100%
Enzyme Inhibition
100%
Cytolytic
100%
Osseous
100%
Telomerase Enzyme
100%
Androgen-independent
100%
Prostate Cancer
42%
Femur
42%
Histology
28%
Combination Treatment
28%
Triple Therapy
28%
Histomorphometry
28%
Nude Mice
28%
Telomerase Inhibitor
28%
C4-2B
28%
Docetaxel
14%
Clinical Trials
14%
Fibrosis
14%
Virus
14%
Treatment Study
14%
Histological Analysis
14%
Apoptosis
14%
Intraosseous
14%
Treatment Group
14%
Recurrent Prostate Cancer
14%
Multiple Comparisons
14%
Cytotoxic Therapy
14%
Enzyme Inhibitors
14%
Statistical Analysis Method
14%
Repeated Measures Analysis
14%
Woven Bone
14%
Bonferroni Method
14%
Tumor Bone
14%
Synthetic Small Molecules
14%
Serum PSA
14%
Subcutaneous Xenograft
14%
Double Therapy
14%
Multiple Lines
14%
Medicine and Dentistry
Prostate Cancer
100%
Telomerase
100%
Androgen
100%
Enzyme Inhibition
100%
Telomerase Inhibitor
28%
Clinical Trial
14%
Virus
14%
Programmed Cell Death
14%
Xenograft
14%
Fibrosis
14%
Morphometrics
14%
Cytotoxic Chemotherapy
14%
Enzyme Inhibitor
14%
Femur Tumor
14%
Docetaxel
14%
Treatment Group
14%
Veterinary Science and Veterinary Medicine
Androgen
100%
Prostate Cancer
100%
Mouse
80%
Small Molecule
20%
Morphometrics
20%
Morphometry
20%
Neoplasm
20%
Immunology and Microbiology
Prostate
100%
Enzyme Inhibition
100%
Nude Mouse
33%
Xenograft
16%
Virus
16%
Programmed Cell Death
16%